Testing effectiveness (Phase 2)Study completedNCT01133665What this trial is testingCetuximab and Lenalidomide in Head and NeckWho this might be right forSquamous Cell Carcinoma University of Chicago 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05784012What this trial is testingTwo-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 34
Not applicableStudy completedNCT01466257What this trial is testingBiomarkers in Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer ECOG-ACRIN Cancer Research Group 70
Testing effectiveness (Phase 2)Ended earlyNCT03361228What this trial is testingEvaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 5
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT07040072What this trial is testingFinotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCCWho this might be right forHNSCC Beijing Tongren Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877What this trial is testingPhase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationWho this might be right forNon-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more Merus B.V. 194
Testing effectiveness (Phase 2)Looking for participantsNCT05674396What this trial is testing3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized TrialWho this might be right forHead and Neck Squamous Cell Carcinoma M.D. Anderson Cancer Center 108
Testing effectiveness (Phase 2)Study completedNCT05156970What this trial is testingCamrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCCWho this might be right forRecurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Not applicableLooking for participantsNCT06061705What this trial is testingIdentification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to ImmunotherapiesWho this might be right forSquamous Cell Carcinoma of the Oropharynx Fondation Hôpital Saint-Joseph 100
Testing effectiveness (Phase 2)Study completedNCT00815295What this trial is testingStudy of Sorafenib/Cetuximab in Head and Neck CancerWho this might be right forSquamous Cell Cancer Duke University 31
Testing effectiveness (Phase 2)UnknownNCT00637637What this trial is testingExternal-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesWho this might be right forCancer Oncology Institute of Southern Switzerland 60
Early research (Phase 1)Study completedNCT00404339What this trial is testingVaccine Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Robert Ferris 17
Not applicableStudy completedNCT06031337What this trial is testingSalivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy StudyWho this might be right forOral CancerOral Squamous Cell Carcinoma Fayoum University 46
Early research (Phase 1)Study completedNCT00083057What this trial is testingGefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer National Institutes of Health Clinical Center (CC) 30
Not applicableStudy completedNCT06730412What this trial is testingCtDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)Who this might be right forHPV Positive Oropharyngeal Squamous Cell Carcinoma Massachusetts Eye and Ear Infirmary 103
Testing effectiveness (Phase 2)Looking for participantsNCT07063212What this trial is testingSacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)Who this might be right forSquamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00519077What this trial is testingPhase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Neoplasms University of Chicago 44
Very early researchLooking for participantsNCT06305962What this trial is testing177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsWho this might be right forPDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more Radiopharm Theranostics, Ltd 30
Large-scale testing (Phase 3)WithdrawnNCT03342352What this trial is testingNivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)Who this might be right forHead and Neck Cancer Incyte Corporation